Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Reem Karmali, MD, Hagop Youssoufian, MD, Kam Sprott, PhD, David T. Weaver, PhD, Narayana Narasimhan, Stephanie Lustgarten, PhD, Gloria Patrick, Alena Zalutskaya, Leo I. Gordon, MD

Blood (2019) 134 (Supplement_1): 5251.

https://doi.org/10.1182/blood-2019-124406

Published: 2019

Journal Articles

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Ye Chen, Xiuchuan Qin, Xue Han, Beibei Bai, Yingchun Wang

Blood (2019) 134 (Supplement_1): 5375.

https://doi.org/10.1182/blood-2019-124612

Published: 2019

Journal Articles

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

Marie-Léa Piel-Julian, Marie-Françoise Thiercelin-Legrand, MD, Guillaume Moulis, MD PhD, Sophie Voisin, MD, Ségolène Claeyssens, Laurent Sailler, MD PhD

Blood (2018) 132 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2018-99-117101

Published: 2018

Journal Articles

The Role of Sphingomyelin (SM) in Tissue Factor (TF) Encryption: ATP-Induced Activation of Acid Sphingomyelinase in Macrophages Decrypts Tissue Factor By Hydrolysis of SM in the Outer Leaflet

Jue Wang, PhD, Usha R Pendurthi, PhD, L. Vijaya Mohan Rao, PhD

Blood (2016) 128 (22): 16.

https://doi.org/10.1182/blood.V128.22.16.16

Published: 2016

Journal Articles

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Blood (2016) 128 (22): 5536.

https://doi.org/10.1182/blood.V128.22.5536.5536

Published: 2016

Journal Articles

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Manuel Ayala, MD, Jacqueline Domínguez, NL, Iván Bonilla, MD

Blood (2016) 128 (22): 5430.

https://doi.org/10.1182/blood.V128.22.5430.5430

Published: 2016

Journal Articles

Platelet-Induced T Cell Activation in Patients with Myocardial Infarction; The Role of miR155

Elena E. Solomou, MD PhD, Elena Kalyvioti, Evgenia Verigou, MD PhD, Katerina Katsanaki, Charalambos Gogos, George Hahalis, Dimitrios Alexopoulos, MD PhD

Blood (2016) 128 (22): 4913.

https://doi.org/10.1182/blood.V128.22.4913.4913

Published: 2016

Journal Articles

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Ellen K. Ritchie, MD, Rose Catchatourian, MD, Rebecca B Klisovic, MD, Javier Pinilla-Ibarz, MD PhD, Michael W. Deininger, MD PhD, Harry P. Erba, MD PhD, Jerald P. Radich, Michael R. Savona, MD, Ilva Dautaj, MS, Johannes Wolff, MD, Michael J. Mauro, MD

Blood (2016) 128 (22): 3090.

https://doi.org/10.1182/blood.V128.22.3090.3090

Published: 2016

Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD

Blood (2015) 126 (23): 4031.

https://doi.org/10.1182/blood.V126.23.4031.4031

Published: 2015

Journal Articles

Platelets from Patients with Myocardial Infarction Can Activate T Cells in Vitro

Elena E. Solomou, MD PhD, Vasilios Gizas, MD, Theodora Babali, MD, Angelos Perperis, MD, Evgenia Verigou, MD PhD, Periklis Ntavlouros, MD PhD, Charalambos Gogos, MD PhD, Dimitrios Alexopoulos, MD PhD

Blood (2015) 126 (23): 3448.

https://doi.org/10.1182/blood.V126.23.3448.3448

Published: 2015

Journal Articles

D-Dimer in the Months Leading up to Acute Coronary Events: A Case Crossover Study

David Green, MD PhD, Yihua Liao, MS, Loyda Vida, D Min, Philip Greenland, MD, Mark D Huffman, MD MPH, Kiang J Liu, PhD, Donald M Lloyd-Jones, MD, Sanjiv J Shah, MD, Lu Tian, PhD, Russell P Tracy, PhD, John T Wilkins, MD, Lihui Zhao, PhD, Mary M McDermott, MD

Blood (2014) 124 (21): 2864.

https://doi.org/10.1182/blood.V124.21.2864.2864

Published: 2014

Journal Articles

Long Term Follow-up of 107 Patients with Essential Thrombocythemia: Role of Cardiovascular Events

Eleonora Arboscello, MD, Elisa Molinari, MD, Andrea Bellodi, MD, Lisette Del Corso, MD, Serena Favorini, MD, Vera Sicbaldi, MD, Jacopo Agnelli Giacchello, MD, Chiara Salvetti, MD, Enrico Balleari, MD, Riccardo Ghio, PhD MD, Maria Teresa Van Lint, MD

Blood (2014) 124 (21): 5566.

https://doi.org/10.1182/blood.V124.21.5566.5566

Published: 2014

Journal Articles

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Anna G. Turkina, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Vasiliy Shuvaev, Galina Gusarova, MD PhD, Anastasia Bykova, MD, Olga V. Lazareva, PhD, Oleg Shukhov, MD, Adham Abdullaev, MD PhD, Irina Martynkevich, Kudrat Abdulkadyrov, MD

Blood (2014) 124 (21): 5518.

https://doi.org/10.1182/blood.V124.21.5518.5518

Published: 2014

Journal Articles

Incidence of Arterial and Venous Thrombosis in Vonwillebrand Disease

Syed Hassan, MD, Waqas Qureshi, MD, Syed Amer, Mohamed Almahmoud, MD, Vrushali S. Dabak, MD, Philip Kuriakose, MD

Blood (2012) 120 (21): 101.

https://doi.org/10.1182/blood.V120.21.101.101

Published: 2012

Journal Articles

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Sagar Lonial, MD, Ruben Niesvizky, MD, Leanne McCulloch, PharmD, Kanya Rajangam, MD, PhD, Ravi Vij, MD

Blood (2012) 120 (21): 4037.

https://doi.org/10.1182/blood.V120.21.4037.4037

Published: 2012

Journal Articles

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Tetsuya Tanimoto, MD, Yasuo Oshima, MD, PhD, FACP, Koichiro Yuji, M.D., Ph.D., Masahiro Kami, MD, PhD

Blood (2011) 118 (21): 1698.

https://doi.org/10.1182/blood.V118.21.1698.1698

Published: 2011

Journal Articles

Platelet Activation in Cardiovascular Disease

Giorgio Corinaldesi, MD, PhD

Blood (2011) 118 (21): 5242.

https://doi.org/10.1182/blood.V118.21.5242.5242

Published: 2011

Journal Articles

Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopaedic Surgery: Findings From Four Phase III Trials

Bengt I Eriksson, MD, John J Smith, MD, PhD, Joseph Caprini, MD, Stefan Hantel, PhD, Andreas Clemens, MD, Martin Feuring, MD, Gregory W Barsness, MD

Blood (2011) 118 (21): 2309.

https://doi.org/10.1182/blood.V118.21.2309.2309

Published: 2011

Journal Articles

Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience

Danny Hsu, MBBS FRACP FRCPA, Ibrahim Tohidi-Esfahani, MBBS, Christina Brown, MBBS PhD FRACP FRCPA, Scott Dunkley, MBBS FRACP FRCPA, Stephen Robert Larsen, MBBS FRACP FRCPA PhD, Phoebe Joy Ho, MBBS FRCPA FRACP DPhil, Harry Iland, MBBS FRACP FRCPA MHGSA, John Gibson, MBBS FRACP FRCPA DPhil, Douglas E. Joshua, MBBS DPhil FRACP FRCPA AM

Blood (2011) 118 (21): 4957.

https://doi.org/10.1182/blood.V118.21.4957.4957

Published: 2011

Journal Articles

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, Roger M Lyons, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood (2010) 116 (21): 68.

https://doi.org/10.1182/blood.V116.21.68.68

Published: 2010

NARROW

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Study on the Possibility of Emergency Percutaneous Coronary Intervention (PCI) in Myeloproliferative Neoplasms (MPNs) Patients with Acute Coronary Syndrome (ACS)

Antithrombotic Therapy Management in Patients with Inherited Bleeding Disorders and Ischaemic Heart Disease: A Single-Center Experience

The Role of Sphingomyelin (SM) in Tissue Factor (TF) Encryption: ATP-Induced Activation of Acid Sphingomyelinase in Macrophages Decrypts Tissue Factor By Hydrolysis of SM in the Outer Leaflet

Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Platelet-Induced T Cell Activation in Patients with Myocardial Infarction; The Role of miR155

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Platelets from Patients with Myocardial Infarction Can Activate T Cells in Vitro

D-Dimer in the Months Leading up to Acute Coronary Events: A Case Crossover Study

Long Term Follow-up of 107 Patients with Essential Thrombocythemia: Role of Cardiovascular Events

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Incidence of Arterial and Venous Thrombosis in Vonwillebrand Disease

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Platelet Activation in Cardiovascular Disease

Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopaedic Surgery: Findings From Four Phase III Trials

Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only